GSK plc 4
4 · Wave Life Sciences Ltd. · Filed Dec 15, 2025
Insider Transaction Report
Form 4
GLAXOSMITHKLINE PLC
10% Owner
Transactions
- Purchase
Ordinary Shares
2025-12-11$19.00/sh+1,470,000$27,930,000→ 18,245,691 total(indirect: By Corporation)
Footnotes (1)
- [F1]The shares reported herein are held of record by Glaxo Group Limited, a wholly-owned subsidiary of GSK plc (the "Reporting Person").